Liquid Biopsy in Organ Damage: small extracellular vesicle chip-based assessment of polytrauma

Front Immunol. 2023 Nov 15:14:1279496. doi: 10.3389/fimmu.2023.1279496. eCollection 2023.

Abstract

Background: Despite major advances in medicine, blood-borne biomarkers are urgently needed to support decision-making, including polytrauma. Here, we assessed serum-derived extracellular vesicles (EVs) as potential markers of decision-making in polytrauma.

Objective: Our Liquid Biopsy in Organ Damage (LiBOD) study aimed to differentiate polytrauma with organ injury from polytrauma without organ injury. We analysed of blood-borne small EVs at the individual level using a combination of immunocapture and high-resolution imaging.

Methods: To this end, we isolated, purified, and characterized small EVs according to the latest Minimal Information for Studies of Extracellular Vesicles (MISEV) guidelines from human blood collected within 24 h post-trauma and validated our results using a porcine polytrauma model.

Results: We found that small EVs derived from monocytes CD14+ and CD14+CD61+ were significantly elevated in polytrauma with organ damage. To be precise, our findings revealed that CD9+CD14+ and CD14+CD61+ small EVs exhibited superior performance compared to CD9+CD61+ small EVs in accurately indicating polytrauma with organ damage, reaching a sensitivity and a specificity of 0.81% and 0.97%, respectively. The results in humans were confirmed in an independent porcine model of polytrauma.

Conclusion: These findings suggest that these specific types of small EVs may serve as valuable, non-invasive, and objective biomarkers for assessing and monitoring the severity of polytrauma and associated organ damage.

Keywords: biomarker; exosomes; extracellular vesicles; liquid biopsy; monocytes; trauma; triage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers
  • Extracellular Vesicles* / pathology
  • Humans
  • Liquid Biopsy
  • Monocytes
  • Multiple Trauma* / pathology
  • Swine

Substances

  • Biomarkers

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Studies were supported by the German Armed Forces (Bundeswehr, project number 31K1-S-10 2023) to AW, SS, RS, AGW, and MTK and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) to MTK (DFG project number 410853455). VL-K is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy (EXC 2151 – 390873048) and DFG Project numbers 411345524 and 432325352.